Discover the latest guidelines for diagnosing, evaluating, and risk stratifying in upper tract urothelial carcinoma (UTUC) patients in our dynamic, expert-led, on-demand video. Learn how to apply current evidence to select the most suitable therapies and sequences for patients, considering safety, efficacy, and administration routes. Delve into the mechanism behind novel chemoablation strategies through a dynamic whiteboard video explanation, enhancing your understanding of its action and potential impact on treatment outcomes.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/latest-advances-low-grade-utuc-therapies
- Start Date: 2024-08-30 05:00:00
- End Date: 2024-08-30 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Urogen Pharma, Inc. - Amount: 31583.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest